Health is typically a big spend area in federal budgets. Last night's is getting mixed reviews, with one lobby group describing it as a "missed opportunity". But there are also positives. The cost of medicines listed on the pharmaceutical benefits scheme will be frozen for a year, offering some reprieve to the growing cost of living.